baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Gamma Plus I/ DE000A2PYPU8 /

NAV2024-04-24	Chg.+0.0700	Type of yield	Investment Focus	Investment company
105.3400EUR	+0.07%	reinvestment	Alternative Investments Worldwide	HANSAINVEST ▶

GlobeNewswire 04-24 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...

GlobeNewswire 04-24 SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society ...

GlobeNewswire 04-24 IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2...

GlobeNewswire 04-22 GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Me...

GlobeNewswire 04-22 Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defe...

GlobeNewswire 04-18 IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101

GlobeNewswire 04-18 American Shared Hospital Services Strengthens Senior Management Structure

GlobeNewswire 04-16 IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire 04-16 Standard Uranium Reports on Recent Exploration Insights at the Sun Dog Project with Option Partner A...

GlobeNewswire 04-15 Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

GlobeNewswire 04-15 Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults w...

GlobeNewswire 04-13 American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione

GlobeNewswire 04-11 IMUNON Reports Compliance with Nasdaq Listing Requirements

GlobeNewswire 04-11 Standard Uranium Intersects Anomalous Radioactivity, Prospective Structure and Alteration in Multipl...

GlobeNewswire 04-10 AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024

GlobeNewswire 04-09 ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in...

GlobeNewswire 04-09 IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

GlobeNewswire 04-09 Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Associati...

GlobeNewswire 04-08 Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform T...

GlobeNewswire 04-05 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association f...

GlobeNewswire 04-05 Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

GlobeNewswire 04-04 FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a ...

GlobeNewswire 04-03 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...

GlobeNewswire 04-02 Global Uranium Production to Increase as Prices Are Expected to Hit a 15 Year High

GlobeNewswire 04-01 Guggenheim Investments Announces April 2024 Closed-End Fund Distributions

Gamma Plus I/ DE000A2PYPU8 /

If you wish to receive reply to your feedback, please provide your email address.